Global Cholestatic Pruritus Market Size, Share, and COVID-19 Impact Analysis, By Therapeutic Class (Biologics, Small Molecule Inhibitors, Topical Agents, Systemic Corticosteroids, and Others), By Indication (Chronic Kidney Disease-Associated Pruritus (CKD-aP), Atopic Dermatitis, Psoriasis, Cholestatic Pruritus, and Other Dermatological Conditions), By Route of Administration (Injectable, Oral, Topical, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Industry: Healthcare
Need help to buy this report?
Inquiry Before Buy